Profile data is unavailable for this security.
About the company
Tsubota Laboratory Inc is a Japan-based company mainly engaged in the research and development of new treatments for myopia, dry eye, and presbyopia. The Company operates with a B2B business model. The model generates revenue from lump-sum payments under joint research and development agreements and licensing agreements with partner companies, milestone payments, and royalties under post-commercialization (post-launch) loyalty agreements and creates new value by investing the profits in the new research. The Company is also engaged in the research and development of products for adults that treat depression and dementia, improve sleep and increase concentration.
- Revenue in JPY (TTM)673.53m
- Net income in JPY-641.32m
- Incorporated2012
- Employees10.00
- LocationTsubota Laboratory Inc8FAoyama KK Bldg., 2-26-35, Minami-AoyamaSHINJUKU-KU 160-0016JapanJPN
- Phone+81 363842866
- Websitehttps://tsubota-lab.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| K Pharma Inc | 500.00m | -221.98m | 7.19bn | 15.00 | -- | 2.51 | -- | 14.39 | -18.94 | -18.94 | 43.04 | 247.43 | 0.2095 | 4.49 | -- | 33,333,330.00 | -9.30 | -- | -9.83 | -- | 91.00 | -- | -44.40 | -- | 42.60 | -- | -- | -- | -- | -- | 166.34 | -- | -- | -- |
| Symbio Pharmaceuticals Ltd | 4.64bn | -2.74bn | 7.30bn | 109.00 | -- | 1.02 | -- | 1.57 | -66.88 | -66.88 | 113.80 | 156.38 | 0.5439 | 2.76 | 5.14 | 42,594,130.00 | -32.15 | -19.18 | -35.33 | -23.62 | 78.38 | 65.84 | -59.12 | -24.32 | 10.43 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| Carna Biosciences, Inc. | 1.58bn | -1.03bn | 7.48bn | 67.00 | -- | 2.12 | -- | 4.74 | -60.32 | -60.32 | 92.24 | 205.19 | 0.3574 | 1.24 | 12.63 | 23,578,990.00 | -23.36 | -14.45 | -25.26 | -16.95 | 89.03 | 90.59 | -65.36 | -35.42 | 13.18 | -- | 0.0326 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
| Kohjin Bio Co Ltd | 4.77bn | 384.98m | 7.65bn | 157.00 | 18.17 | 1.90 | 18.77 | 1.60 | 84.00 | 84.00 | 1,039.24 | 802.50 | -- | -- | -- | -- | -- | -- | -- | -- | 39.44 | -- | 8.07 | -- | 1.14 | -- | 0.4249 | -- | 0.5715 | -- | -53.61 | -- | -- | -- |
| Wakamoto Pharmaceutical Co Ltd | 7.98bn | -177.67m | 8.57bn | 292.00 | -- | 0.7296 | 36.84 | 1.07 | -5.12 | -5.12 | 229.89 | 337.15 | 0.525 | 2.08 | 2.88 | 27,324,600.00 | -1.17 | -2.58 | -1.34 | -3.00 | 46.98 | 53.08 | -2.23 | -4.33 | 3.45 | -- | 0.0085 | -- | 3.31 | -4.50 | -42.04 | 1.88 | -17.49 | 0.00 |
| CanBas Co Ltd (Parent) | 0.00 | -1.09bn | 9.35bn | 12.00 | -- | 3.12 | -- | -- | -64.47 | -64.47 | 0.00 | 166.10 | 0.00 | -- | -- | 0.00 | -43.91 | -65.86 | -45.99 | -79.11 | -- | -- | -- | -1,094.10 | -- | -- | 0.00 | -- | -- | -- | -45.41 | -- | -- | -- |
| TMS Co Ltd | 0.00 | -960.04m | 9.63bn | 14.00 | -- | 2.79 | -- | -- | -25.89 | -25.89 | 0.00 | 85.77 | 0.00 | -- | -- | -- | -26.14 | -- | -26.78 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -11.51 | -- | -- | -- |
| Tsubota Laboratory Inc | 673.53m | -641.32m | 9.64bn | 10.00 | -- | 7.05 | -- | 14.32 | -25.15 | -25.15 | 26.42 | 53.45 | 0.2711 | 2.04 | 37.74 | -- | -25.82 | -- | -36.41 | -- | 3.17 | -- | -95.22 | -- | 2.31 | -489.86 | 0.0788 | -- | -29.45 | -- | -811.14 | -- | -- | -- |
| Linical Co Ltd | 12.52bn | 680.40m | 10.09bn | 759.00 | 13.54 | 1.18 | 8.49 | 0.8063 | 30.12 | 30.12 | 554.28 | 346.38 | 0.7251 | -- | 3.99 | 16,494,230.00 | 3.94 | 4.71 | 6.55 | 7.23 | 33.10 | 31.60 | 5.43 | 5.98 | -- | 17,809.03 | 0.2793 | 45.36 | 8.32 | 6.55 | 27.06 | -4.97 | -33.01 | 4.94 |
| AnGes Inc | 249.94m | -6.35bn | 10.58bn | 145.00 | -- | 0.3777 | -- | 42.32 | -32.62 | -32.62 | 1.29 | 124.45 | 0.0077 | 0.0862 | 4.77 | 1,723,752.00 | -19.47 | -28.50 | -23.06 | -33.14 | 39.85 | 39.42 | -2,540.59 | -6,726.82 | 0.9124 | -- | 0.0139 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
| 3-D Matrix Ltd | 3.74bn | -1.06bn | 10.61bn | 108.00 | -- | 16.79 | -- | 2.84 | -14.90 | -14.90 | 54.06 | 7.74 | 0.6653 | 0.4654 | 5.19 | 34,630,130.00 | -18.91 | -57.69 | -23.28 | -77.31 | 64.04 | 40.76 | -28.43 | -205.34 | 2.33 | -- | 0.8717 | -- | 53.63 | 58.87 | -29.09 | -- | -7.69 | -- |
| KOEI CHEMICAL COMPANY, LIMITED | 19.43bn | 299.18m | 11.12bn | 387.00 | 37.11 | 0.5089 | 4.76 | 0.5726 | 61.17 | 61.17 | 3,971.90 | 4,460.94 | 0.4957 | 1.66 | 3.80 | -- | 0.7659 | 3.15 | 0.997 | 3.94 | 27.17 | 25.24 | 1.55 | 5.85 | 0.6907 | 115.66 | 0.3207 | 43.88 | 4.44 | 1.19 | -56.72 | -20.82 | -3.29 | 10.76 |
| Medinet Co Ltd | 711.82m | -1.40bn | 11.80bn | 98.00 | -- | 2.12 | -- | 16.58 | -6.00 | -6.00 | 3.03 | 21.73 | 0.124 | 11.34 | 3.78 | 7,263,510.00 | -24.31 | -21.05 | -25.48 | -22.47 | 15.25 | 28.75 | -196.06 | -135.40 | 20.08 | -- | 0.00 | -- | 4.40 | -7.90 | -14.66 | -- | -17.67 | -- |
| ReproCell Inc | 2.43bn | -31.42m | 11.81bn | 92.00 | -- | 1.41 | 155.68 | 4.87 | -0.3465 | -0.3465 | 28.34 | 93.45 | 0.2788 | 5.41 | 5.60 | -- | -0.3609 | -7.35 | -0.3932 | -8.00 | 46.19 | 39.83 | -1.29 | -27.16 | 10.54 | -- | -- | -- | -17.83 | 17.39 | 89.71 | -- | 13.27 | -- |
| Stella Pharma Corp | 269.49m | -763.75m | 11.87bn | 46.00 | -- | 4.99 | -- | 44.03 | -24.63 | -24.63 | 8.70 | 76.12 | 0.0661 | 0.0508 | 3.98 | -- | -18.74 | -22.50 | -21.00 | -24.83 | 80.63 | -- | -283.40 | -488.65 | 5.52 | -379.39 | 0.2819 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
Data as of May 20 2024. Currency figures normalised to Tsubota Laboratory Inc's reporting currency: Japanese Yen JPY
1.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Asset Management One Co., Ltd.as of 15 May 2023 | 273.70k | 1.07% |
| Simplex Asset Management Co., Ltd.as of 09 May 2024 | 36.00k | 0.14% |
| Fivestar Asset Management Co. Ltd.as of 25 Sep 2023 | 14.00k | 0.06% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 19 Sep 2023 | 800.00 | 0.00% |
More ▼
Data from 25 Sep 2023 - 09 May 2024Source: FactSet Research Systems Inc.
